People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Judo Bio Inc. | — | Biotechnology | Series B | $55.0M | $172.2M | 2022 |
| Korro Bio, Inc. | — | Biotechnology | Seed | $4.0M | $177.6M | 2019 |
OMMER CHOHAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside OMMER CHOHAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jean-Francois Formela | 1 | 17 |
| Kevin Bitterman | 1 | 15 |
| Nessan Bermingham | 1 | 3 |
| ANKIT JEFFREY MAHADEVIA | 1 | 1 |
| JAMES JEFFREY GOATER | 1 | 1 |
| SAM JEFFREY BJORK | 1 | 1 |
| CHELSEA PLACE JOHNSON | 1 | 1 |
| HUI JEFFREY TIAN | 1 | 1 |
| ROBERT GAFFEY | 1 | 1 |
| GEORGE JEFFREY GOLUMBESKI | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.